Human Medicines
This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Information on nitrosamines for marketing authorisation holders
modified 23/11/2022
Added in November 2022
17 November
NEW - Presentations from the CMDh meeting…
modified 17/11/2022
Meeting with Interested Parties - 9 November 2022
Presentations Medicines…
modified 17/11/2022
List of active substances for which data has been submitted in accordance with…
modified 16/11/2022
Zithromax (azithromycin (dehydrate)) PT/W/0007/pdWS/001 End of procedure:…
modified 16/11/2022
Haemophilus influenzae type b [Hib] conjugate vaccine (act-HIB) End of…
modified 16/11/2022
Haemophilus influenzae type b [Hib] conjugate vaccine (Act-HIB) End of…
modified 16/11/2022
Haemocomplettan¸Riastap (human fibrinogen) End of procedure: 30/11/2011 Date…
modified 16/11/2022
Dexilant (dexlansoprazole) End of procedure: 02/03/2016 Date of publication:…
modified 16/11/2022
Decapeptyl / Diphereline /Arvekap (triptorelin pamoate) End of procedure:…
modified 16/11/2022